These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28987491)

  • 1. Treatment for facial alopecia areata: A systematic review with evidence-based analysis.
    Murad A; Bergfeld W
    J Am Acad Dermatol; 2018 Mar; 78(3):601-605. PubMed ID: 28987491
    [No Abstract]   [Full Text] [Related]  

  • 2. Current treatment of alopecia areata.
    Shapiro J
    J Investig Dermatol Symp Proc; 2013 Dec; 16(1):S42-4. PubMed ID: 24326551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of latanoprost in the treatment of alopecia areata of eyelashes and eyebrows.
    Faghihi G; Andalib F; Asilian A
    Eur J Dermatol; 2009; 19(6):586-7. PubMed ID: 19620039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous latanoprost in the treatment of alopecia areata.
    Mehta JS; Raman J; Gupta N; Thoung D
    Eye (Lond); 2003 Apr; 17(3):444-6. PubMed ID: 12724722
    [No Abstract]   [Full Text] [Related]  

  • 5. Alopecia areata.
    Perera E; Yip L; Sinclair R
    Curr Probl Dermatol; 2015; 47():67-75. PubMed ID: 26370645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of diphenylcyclopropenone alone or in combination with anthralin in the treatment of chronic extensive alopecia areata: a retrospective case series.
    Durdu M; Özcan D; Baba M; Seçkin D
    J Am Acad Dermatol; 2015 Apr; 72(4):640-50. PubMed ID: 25653027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of alopecia areata in children.
    Mukherjee N; Burkhart CN; Morrell DS
    Pediatr Ann; 2009 Jul; 38(7):388-95. PubMed ID: 19685659
    [No Abstract]   [Full Text] [Related]  

  • 8. Alopecia Areata-Part III: Prognosis and Treatment.
    Estefan J; Ribeiro M; Abad E; Saintive S; Ramos-E-Silva M
    Skinmed; 2016; 14(5):361-365. PubMed ID: 27871349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment-resistant alopecia areata. Response to combination therapy with minoxidil plus anthralin.
    Fiedler VC; Wendrow A; Szpunar GJ; Metzler C; DeVillez RL
    Arch Dermatol; 1990 Jun; 126(6):756-9. PubMed ID: 2140670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin analogs for hair growth: greater expectations.
    Namazi MR
    Dermatol Online J; 2003 Dec; 9(5):29. PubMed ID: 14996402
    [No Abstract]   [Full Text] [Related]  

  • 11. Systematic review and quality analysis of studies on the efficacy of topical diphenylcyclopropenone treatment for alopecia areata.
    Jang YH; Jung HJ; Moon SY; Lee WJ; Lee SJ; Lee WK; Kim DW
    J Am Acad Dermatol; 2017 Jul; 77(1):170-172.e1. PubMed ID: 28619558
    [No Abstract]   [Full Text] [Related]  

  • 12. Photographic assessment improves adherence to recommended follow-up in patients with androgenetic alopecia and alopecia areata: A retrospective cohort study.
    Lee S; Lee H; Lee CH; Lee WS
    Indian J Dermatol Venereol Leprol; 2019; 85(4):431-433. PubMed ID: 31062723
    [No Abstract]   [Full Text] [Related]  

  • 13. Bimatoprost for the treatment of eyelash, eyebrow and scalp alopecia.
    Barrón-Hernández YL; Tosti A
    Expert Opin Investig Drugs; 2017 Apr; 26(4):515-522. PubMed ID: 28264599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful use of bimatoprost in the treatment of alopecia of the eyelashes.
    Zaheri S; Hughes B
    Clin Exp Dermatol; 2010 Jun; 35(4):e161-2. PubMed ID: 19925481
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of topical latanoprost versus minoxidil and betamethasone valerate on the treatment of alopecia areata.
    El-Ashmawy AA; El-Maadawy IH; El-Maghraby GM
    J Dermatolog Treat; 2018 Feb; 29(1):55-64. PubMed ID: 28521549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial of diphenylcyclopropenone (DPCP) combined with anthralin versus DPCP alone for treating moderate to severe alopecia areata.
    Ghandi N; Daneshmand R; Hatami P; Abedini R; Nasimi M; Aryanian Z; Vance TM
    Int Immunopharmacol; 2021 Oct; 99():107971. PubMed ID: 34298402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of efficacy of topical latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients with alopecia areata.
    Roseborough I; Lee H; Chwalek J; Stamper RL; Price VH
    J Am Acad Dermatol; 2009 Apr; 60(4):705-6. PubMed ID: 19293023
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: a clinical and immunopathologic evaluation.
    Shapiro J; Tan J; Ho V; Tron V
    J Invest Dermatol; 1995 May; 104(5 Suppl):36S. PubMed ID: 7738390
    [No Abstract]   [Full Text] [Related]  

  • 19. Alopecia areata.
    Wasserman D; Guzman-Sanchez DA; Scott K; McMichael A
    Int J Dermatol; 2007 Feb; 46(2):121-31. PubMed ID: 17269961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines for the management of alopecia areata.
    MacDonald Hull SP; Wood ML; Hutchinson PE; Sladden M; Messenger AG;
    Br J Dermatol; 2003 Oct; 149(4):692-9. PubMed ID: 14616359
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.